Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2021-04-15 M&A Activity
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
METEX : Signature of the Share Purchase Agreement (SPA) for the transfer of 100% of the capital of Ajinomoto Animal Nutrition Europe (AANE).
M&A Activity Classification · 1% confidence The document is a press release dated April 15, 2021, announcing the signature of a Share Purchase Agreement (SPA) for the acquisition of 100% of Ajinomoto Animal Nutrition Europe (AANE). This announcement details a significant corporate transaction (M&A activity) and financing implications (price paid from equity). Although it mentions future financial reports (Annual Financial Report on April 29), the core content is the announcement of the transaction itself. This fits best under the M&A Activity category (TAR). It is not a formal regulatory filing like a 10-K, nor is it a general regulatory announcement (RNS) since a more specific category applies.
2021-04-15 English
METEX : Signature du Contrat d'Acquisition concernant le transfert de 100% du capital d'Ajinomoto Animal Nutrition Europe (AANE).
M&A Activity Classification · 1% confidence The document announces the signing of an acquisition agreement for 100% of Ajinomoto Animal Nutrition Europe (AANE). It details the financial terms (15 M€ acquisition price), strategic rationale (becoming a leader in functional ingredients via fermentation), and future integration plans. This type of announcement, concerning a major corporate transaction like an acquisition, falls under the category of M&A Activity (TAR). It is not a standard periodic report (10-K, IR, ER) nor a general regulatory filing (RNS). The document is a formal press release detailing a transaction.
2021-04-15 French
Déclaration du nombre total d'Actions et Droits de Votes au capital social le 31/03/2021
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Déclaration du nombre total de Droits de Vote et d'Actions au capital social le 31/03/2021" (Declaration of the total number of Voting Rights and Shares in the share capital as of 03/31/2021) and explicitly references Article 223-16 of the AMF general regulation. It details the total number of shares, theoretical voting rights, and exercisable voting rights. This content directly relates to the official declaration of voting rights and share structure, which aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a simple dividend notice.
2021-04-09 French
Mise à jour - Déclaration du nombre total d'Actions et Droits de Votes au capital social le 31/01/2021
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Déclaration du nombre total de Droits de Vote et d'Actions au capital social le 31/01/2021" (Declaration of the total number of Voting Rights and Shares in the share capital as of 01/31/2021) and explicitly references Article 223-16 of the AMF general regulation (French financial market authority). It details the total number of shares, theoretical voting rights, and exercisable voting rights. This content directly relates to the official results of shareholder voting rights and capital structure disclosure, which aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a simple dividend notice.
2021-04-09 French
Résultats annuels 2020
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report titled 'Résultats annuels 2020' (Annual Results 2020) for METabolic EXplorer. It contains detailed financial statements (income statement table), management's analysis of the results, operational updates, and financial position details for the fiscal year 2020. It is not a mere announcement of a report, but the report itself, containing substantive financial data and analysis. Therefore, it is classified as an Interim/Quarterly Report (IR) equivalent for annual results. FY 2020
2021-03-29 French
Franchissement de seuil
Director's Dealing Classification · 1% confidence The document is titled "Déclaration de franchissement de seuil (article L. 233-7 du code de commerce)" and details changes in share ownership (crossing the 5% threshold) by an individual (M. Benjamin Gonzalez) in METABOLIC EXPLORER. This type of mandatory disclosure regarding changes in significant shareholdings directly corresponds to the definition of Major Shareholding Notification. The document explicitly reports the number of shares held, the percentage of capital, and the resulting voting rights, which is the core function of a major shareholding notification.
2021-03-29 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.